Abstract
We present preliminary in-vivo validation of VASCOVID device, a hybrid diffuse optical platform designed for automatized microvasculature health assessment in the intensive care. The in-vivo validation was run on more than hundred subjects.
| Original language | English |
|---|---|
| Publication status | Published - 2024 |
| Event | 2024 Clinical and Translational Biophotonics, Translational 2024 - Part of Optica Biophotonics Congress: Biomedical Optic - Fort Lauderdale, United States Duration: 7 Apr 2024 → 10 Apr 2024 |
Conference
| Conference | 2024 Clinical and Translational Biophotonics, Translational 2024 - Part of Optica Biophotonics Congress: Biomedical Optic |
|---|---|
| Country/Territory | United States |
| City | Fort Lauderdale |
| Period | 7/04/24 → 10/04/24 |